Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
53,583,544
-
Total 13F shares
-
34,902,859
-
Share change
-
+5,098,448
-
Total reported value
-
$198,249,797
-
Put/Call ratio
-
8.8%
-
Price per share
-
$5.68
-
Number of holders
-
95
-
Value change
-
+$32,047,623
-
Number of buys
-
72
-
Number of sells
-
29
Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) as of Q2 2025
As of 30 Jun 2025,
ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,902,859 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Western Standard LLC, Vivo Capital, LLC, BOONE CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Propel Bio Management, LLC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.